Vertex Pharmaceuticals Inc. Reveals Rise In Q2 Bottom Line

Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its second quarter that increased from the same period last year

The company's bottom line came in at $810.5M, or $3.13 per share. This compares with $67.0 million, or $0.26 per share, in last year's second quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $930.5 million or $3.60 per share for the period.

The company's revenue for the quarter rose 22.9% to $2.20 billion from $1.79 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings (Q2): $810.5M. vs. $67.0 Mln. last year.
-EPS (Q2): $3.13 vs. $0.26 last year.
-Revenue (Q2): $2.20 Bln vs. $1.79 Bln last year.

Full year revenue guidance: $8.6 to $8.8 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT